These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19541458)

  • 1. SSRIs, bone mineral density, and risk of fractures--a review.
    Schwan S; Hallberg P
    Eur Neuropsychopharmacol; 2009 Oct; 19(10):683-92. PubMed ID: 19541458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of selective serotonin reuptake inhibitors on the risk of fracture.
    Richards JB; Papaioannou A; Adachi JD; Joseph L; Whitson HE; Prior JC; Goltzman D;
    Arch Intern Med; 2007 Jan; 167(2):188-94. PubMed ID: 17242321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
    Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
    Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
    Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
    J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?
    Warden SJ; Fuchs RK
    Curr Osteoporos Rep; 2016 Oct; 14(5):211-8. PubMed ID: 27495351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies.
    Haney EM; Warden SJ
    J Musculoskelet Neuronal Interact; 2008; 8(2):133-45. PubMed ID: 18622082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?
    Haney EM; Warden SJ; Bliziotes MM
    Bone; 2010 Jan; 46(1):13-7. PubMed ID: 19664737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.
    Feuer AJ; Demmer RT; Thai A; Vogiatzi MG
    Bone; 2015 Sep; 78():28-33. PubMed ID: 25940460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies.
    Wu Q; Bencaz AF; Hentz JG; Crowell MD
    Osteoporos Int; 2012 Jan; 23(1):365-75. PubMed ID: 21904950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression.
    Fernandes BS; Hodge JM; Pasco JA; Berk M; Williams LJ
    Drugs Aging; 2016 Jan; 33(1):21-5. PubMed ID: 26547857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant medications and osteoporosis.
    Rizzoli R; Cooper C; Reginster JY; Abrahamsen B; Adachi JD; Brandi ML; Bruyère O; Compston J; Ducy P; Ferrari S; Harvey NC; Kanis JA; Karsenty G; Laslop A; Rabenda V; Vestergaard P
    Bone; 2012 Sep; 51(3):606-13. PubMed ID: 22659406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adverse skeletal effects of selective serotonin reuptake inhibitors.
    Tsapakis EM; Gamie Z; Tran GT; Adshead S; Lampard A; Mantalaris A; Tsiridis E
    Eur Psychiatry; 2012 Apr; 27(3):156-69. PubMed ID: 21295451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys.
    Calarge CA; Zimmerman B; Xie D; Kuperman S; Schlechte JA
    J Clin Psychiatry; 2010 Mar; 71(3):338-47. PubMed ID: 20331935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do SSRIs play a role in decreasing bone mineral density?
    Chen F; Hahn TJ; Weintraub NT
    J Am Med Dir Assoc; 2012 Jun; 13(5):413-7. PubMed ID: 22037240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcaneal bone mineral density in young adults prescribed selective serotonin reuptake inhibitors.
    Seifert CF; Wiltrout TR
    Clin Ther; 2013 Sep; 35(9):1412-7. PubMed ID: 23958172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.
    Diem SJ; Blackwell TL; Stone KL; Yaffe K; Haney EM; Bliziotes MM; Ensrud KE
    Arch Intern Med; 2007 Jun; 167(12):1240-5. PubMed ID: 17592096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome.
    Bruyère O; Reginster JY
    Endocrine; 2015 Feb; 48(1):65-8. PubMed ID: 25091520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bones of Contention: A Comprehensive Literature Review of Non-SSRI Antidepressant Use and Bone Health.
    Power C; Duffy R; Mahon J; McCarroll K; Lawlor BA
    J Geriatr Psychiatry Neurol; 2020 Nov; 33(6):340-352. PubMed ID: 31665962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between SSRI use and fractures and the effect of confounding by indication.
    Ziere G; Dieleman JP; van der Cammen TJ; Stricker BH
    Arch Intern Med; 2007 Nov; 167(21):2369-70; author reply 2370-1. PubMed ID: 18040000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.